Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02106936 · ClinicalTrials.gov registry record

Depotentiation in People With Focal Hand Dystonia

A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Terminated
Registry status
6
Enrollment target

NCT02106936: Clinical Trial study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT02106936 is a clinical trial that was terminated before completion, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02106936 was terminated before completion, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

TERMINATED
Registry status
6 participants
Enrollment target

Study Summary

Background: \- Focal hand dystonia (FHD) causes muscles to contract, leading to abnormal movements or postures. Musicians, writers, and athletes often get it. Researchers want to study how patients with this condition learn, a process of the brain that depends on a property called plasticity. Objective: \- To study brain plasticity in people with FHD. Eligibility: * Right-handed adults 18 years and older with FHD. * Healthy, right-handed adult volunteers. Design: * Participants will be screened with medical history, physical exam, pregnancy test, and questionnaire about their right-handedness. * Participants will have 2 study visits on 2 different days. * Participants will sit in a chair and have up to 30 Transcranial Magnetic Stimulation (TMS) pulses on the left side of the head. A brief electrical current passes through a wire coil on the scalp. They will hear a click and may feel a pulling on the skin or muscle twitches. They may have to keep their eyes open and remain alert, tense certain muscles, or perform simple finger movements. * Forty more pulses, with 10 seconds between, will be given on the left side of the head. Some will be small, some big. * Researchers will measure muscle response through small electrodes taped to the right hand. * A cloth cap will be put on the participant s head. Researchers will write on tape on the cap. * Participants will have the r-PAS. An electrical stimulator will be placed on the nerve at the right wrist. Repeated magnetic pulses will be delivered in trains or short bursts together with electrical stimulation of nerve. Participants will receive up to 840 pulses. * Participants will be contacted after a few days for a follow-up check.

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2014-03-05
Est. Completion 2017-06-20

Why NCT02106936 stopped before completion

NCT02106936 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02106936 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02106936 about?

NCT02106936 is a clinical study titled "Depotentiation in People With Focal Hand Dystonia". Background: \- Focal hand dystonia (FHD) causes muscles to contract, leading to abnormal movements or postures. Musicians, writers, and athletes often get it. Researchers want to study how patients with this condition learn, a process of the brain that depends on a property called plasticity. Obje...

What is the current status of trial NCT02106936?

This trial is currently terminated. The enrollment target is 6 participants. The study started on 2014-03-05. Estimated completion is 2017-06-20.

Who is sponsoring clinical trial NCT02106936?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02106936, the US trial registry maintained by the National Library of Medicine. NCT02106936 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.